YU24399A - 1-fenilalkil-1,2,3,6-tetrahidropiridini za tretiranje alzheimer-ovog obolenja - Google Patents

1-fenilalkil-1,2,3,6-tetrahidropiridini za tretiranje alzheimer-ovog obolenja

Info

Publication number
YU24399A
YU24399A YU24399A YU24399A YU24399A YU 24399 A YU24399 A YU 24399A YU 24399 A YU24399 A YU 24399A YU 24399 A YU24399 A YU 24399A YU 24399 A YU24399 A YU 24399A
Authority
YU
Yugoslavia
Prior art keywords
alkyl
alcoxycarbonyl
mono
group
alcoxyl
Prior art date
Application number
YU24399A
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of YU24399A publication Critical patent/YU24399A/sh
Publication of RS49807B publication Critical patent/RS49807B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

Pronalazak se odnosi na jedinjenje formule (I) u kojoj Y predstavlja -CH- ili -N-; R1 predstavlja vodonik, halogen, grupu CF3, (C1-C4) alkil ili (C1-C4) alkoksil; R2 predstavlja grupu metil ili etil; R3 i R4 svaki predstavlja vodonik ili (C1-C3) alkil; X predstavlja (a) (C1-C6) alkil, (C1-C6) alkoksil; (C3-C7) karboksialkil; (C1-C4) alkoksikarbonil (C1-C6) alkil; (C3-C7) karboksialkoksil ili (C1-C4) alkoksikarbonil (C1-C6) alkoksil; (b) radikal koji se bira izmedju (C3-C7) cikloalkil, (C3-C7) cikloalkiloksi; (C3-C7) cikloalkimetil, (C3-C7) cikloalkilamino i cikloheksil, pomenuti radikal moze da bude supstituisan sa jednim halogenom, hidroksi, (C1-C4) alkoksi, karboksi, (C1-C4) alkoksikarbonil, amino, mono- ili di-(C1-C4) alkilamino; (c) grupu koja se bira izmedju fenil, fenoksi, fenilamino, N-(C1-C3) alkilfenilamino, fenilmetil, feniletil, fenilkarbonil, feniltio, fenilsulfonil, fenilsulfinil ili stiril, pomenuta grupa moze da bude mono- ili polisupstituisana za fenil grupu sa halogenom, CF3, (C1-C4) alkil, (C1-C4) alkoksi, cijano, mono- ili di-(C1-C4)alkilamino, (C1-C4) alcilamino, karboksi, (C1-C4)alkoksikarbonil, aminokarbonil, mono- ili di-(C1-C4) alkilaminokarbonil, amino-(C1-C4) alkil, hidroksi (C1-C4) alkil ili halogeno (C1-C4) alkil. Pronalazak se takodje odnosi na postupak za njihovo dobijanje i na farmaceutski preparat koji ih sadrzi. Ova jedinjenja imaju neurotrofroticnu i neuroprotektorsku aktivnost.
YUP-243/99A 1996-12-13 1997-12-12 1-fenilalkil-1,2,3,6- tetrahidropiridini za tretiranje alzheimer-ovog oboljenja RS49807B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615335A FR2757160B1 (fr) 1996-12-13 1996-12-13 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Publications (2)

Publication Number Publication Date
YU24399A true YU24399A (sh) 2001-07-10
RS49807B RS49807B (sr) 2008-08-07

Family

ID=9498641

Country Status (32)

Country Link
US (1) US6034090A (sh)
EP (1) EP0950048B1 (sh)
JP (1) JP3881384B2 (sh)
KR (1) KR100560358B1 (sh)
CN (1) CN1129579C (sh)
AT (1) ATE202561T1 (sh)
AU (1) AU730143B2 (sh)
BR (1) BR9713916A (sh)
CA (1) CA2275353C (sh)
CY (1) CY2274B1 (sh)
CZ (1) CZ289789B6 (sh)
DE (1) DE69705429T2 (sh)
DK (1) DK0950048T3 (sh)
EE (1) EE03763B1 (sh)
ES (1) ES2160977T3 (sh)
FR (1) FR2757160B1 (sh)
GR (1) GR3036643T3 (sh)
HK (1) HK1023997A1 (sh)
HU (1) HU224347B1 (sh)
IL (1) IL130003A (sh)
IS (1) IS1969B (sh)
NO (1) NO312720B1 (sh)
NZ (1) NZ336033A (sh)
PL (1) PL190789B1 (sh)
PT (1) PT950048E (sh)
RS (1) RS49807B (sh)
RU (1) RU2189975C2 (sh)
SI (1) SI0950048T1 (sh)
SK (1) SK283331B6 (sh)
TR (1) TR199901291T2 (sh)
UA (1) UA52707C2 (sh)
WO (1) WO1998025903A1 (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
FR2832405B1 (fr) * 2001-11-19 2004-12-10 Sanofi Synthelabo Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
JP3881384B2 (ja) 2007-02-14
BR9713916A (pt) 2000-02-29
DE69705429D1 (de) 2001-08-02
PT950048E (pt) 2001-12-28
NO992869L (no) 1999-06-11
AU730143B2 (en) 2001-03-01
DK0950048T3 (da) 2001-09-24
NO992869D0 (no) 1999-06-11
HU224347B1 (hu) 2005-08-29
TR199901291T2 (xx) 1999-10-21
IL130003A (en) 2004-09-27
HUP0001185A3 (en) 2002-10-28
CZ211399A3 (cs) 2000-09-13
KR100560358B1 (ko) 2006-03-14
IL130003A0 (en) 2000-02-29
SK283331B6 (sk) 2003-06-03
CA2275353C (en) 2007-05-22
CY2274B1 (en) 2003-07-04
CN1129579C (zh) 2003-12-03
EE9900237A (et) 1999-12-15
HUP0001185A2 (hu) 2000-10-28
CZ289789B6 (cs) 2002-04-17
ES2160977T3 (es) 2001-11-16
WO1998025903A1 (fr) 1998-06-18
RU2189975C2 (ru) 2002-09-27
JP2001505902A (ja) 2001-05-08
US6034090A (en) 2000-03-07
FR2757160A1 (fr) 1998-06-19
CA2275353A1 (en) 1998-06-18
IS1969B (is) 2004-12-15
NZ336033A (en) 2000-12-22
EP0950048A1 (fr) 1999-10-20
CN1240427A (zh) 2000-01-05
KR20000069422A (ko) 2000-11-25
EE03763B1 (et) 2002-06-17
UA52707C2 (uk) 2003-01-15
RS49807B (sr) 2008-08-07
GR3036643T3 (en) 2001-12-31
NO312720B1 (no) 2002-06-24
PL190789B1 (pl) 2006-01-31
AU5489398A (en) 1998-07-03
SK78699A3 (en) 2000-01-18
IS5075A (is) 1999-06-10
FR2757160B1 (fr) 1999-03-12
DE69705429T2 (de) 2002-05-16
PL334071A1 (en) 2000-01-31
ATE202561T1 (de) 2001-07-15
SI0950048T1 (en) 2001-10-31
EP0950048B1 (fr) 2001-06-27
HK1023997A1 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
CA2225746A1 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
MY121733A (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole-3-carboxamide derivative, its salts and their solvates
ZA934143B (en) 1,4-disubstituted piperazines, a process for their preparation and pharmaceutical compositions containing them
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
BG101947A (en) Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
MY114548A (en) New arylglycineamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
CA2247257A1 (en) Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
HUT65127A (en) 1-(3,4-disubstituted phenyl)-tetrazolinone derivatives, herbicidal compositions containing the compounds as active ingredients, processes for producing the active ingredients and compositions and for using them
YU24399A (sh) 1-fenilalkil-1,2,3,6-tetrahidropiridini za tretiranje alzheimer-ovog obolenja
DE69303583D1 (de) 15-Deoxyspergualin analoge Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Therapeutika zur Unterdrückung der Immunabwehr
MY120461A (en) Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia.
GR3030319T3 (en) Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
MY133438A (en) Morpholinobenzamide salts
MXPA02001861A (es) Nuevos inhbidores de la integrina alfav beta3.
RU99115083A (ru) 1-фенилалкил-1,2,3,6-тетрагидропиридины для лечения болезни альцгеймера
MY106879A (en) C-linked pyrazole derivatives